PHILADELPHIA, PA — Cabaletta Bio Inc. (Nasdaq: CABA) has granted stock options covering 385,000 shares to four newly hired employees, using equity compensation to recruit personnel as the Philadelphia biotechnology company advances experimental cell therapies for autoimmune diseases.
The awards, issued under the company’s 2025 Inducement Plan, carry exercise prices ranging from $2.00 to $2.46 per share and vest over four years, according to Cabaletta.
The grants were approved under Nasdaq Listing Rule 5635(c)(4), which permits qualifying employment inducement awards outside shareholder-approved equity compensation plans.
The company awarded options to purchase 200,000 shares at $2.46 each, matching its Nasdaq closing share price on September 21, 2026.
Additional grants cover 100,000 shares at $2.00 per share, based on the September 28 closing price, and 85,000 shares at $2.00 per share, based on the October 2 closing price.
The combined exercise value of the options is $862,000. The awards give recipients the right to purchase shares at the specified prices but do not represent an immediate issuance of all 385,000 shares.
Each option has a 10-year contractual term. One-quarter of the underlying shares will vest on the first anniversary of the applicable grant date, with the remaining 75% vesting in 12 equal quarterly installments over the following three years.
The awards were provided to four non-executive employees as incentives to join Cabaletta. They remain subject to the company’s inducement plan and individual stock option agreements.
Cabaletta is developing targeted cell therapies intended to treat autoimmune diseases, with its lead investigational candidate, rese-cel, progressing through the RESET clinical development program.
Rese-cel is a fully human CD19-directed CAR T-cell therapy incorporating a 4-1BB costimulatory domain.
The company’s clinical development activities span multiple therapeutic areas, including rheumatology, neurology and dermatology.
Cabaletta maintains its headquarters and laboratory operations in Philadelphia.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.